Downregulation of calcineurin gene is associated with glucantime® resiatance in Leishmania infantum

Iranian Journal of Parasitology

Volumn 8, Issue 3, 2013, Pages 359-366

  Khadem Erfan, Mohammad Bagher ^a   Mohebali, Mehdi ^a   Kazemi Rad, Elham ^a   Hajjaran, Homa ^a   Edrissian, Gholamhossein ^a   Mamishi, Setareh ^a   Saffari, Mojtaba ^a   Rafooian, Reza ^a   Heidari, Mansour ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antimonial resistance; Calcineurin gene; cDNA AFLP; Leishmania infantum; Real time RT PCR

Indexed keywords

CALCINEURIN; COMPLEMENTARY DNA; MEGLUMINE ANTIMONATE;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; APOPTOSIS; ARTICLE; DOWN REGULATION; GENE EXPRESSION; GENE SEQUENCE; HUMAN; IC 50; LEISHMANIA INFANTUM; NONHUMAN; PARASITE SURVIVAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VISCERAL LEISHMANIASIS;

EID: 84884125057     PISSN: 17357020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Choi CM, Lerner EA. Leishmaniasis: recognition and management with a focus on the immunocompromised patient. Am J Clin Dermatol. 2002; 3(2):91-105.
2. Varela M RE, Lorena Muñoz D, Robledo SM, Kolli BK, Dutta S, Chang KP, et al. Leishmania (Viannia) panamensis: An in vitro assay using the expression of GFP for screening of antileishmanial drug. Exp Parasitol. 2009; 122(2):134-9.
3. Maltezou HC. Drug resistance in visceral leishmaniasis. J Biomed Biotechnol. 2009; 2010
4. Romero GAS, Boelaert M. Control of visceral leishmaniasis in Latin America-a systematic review. PLoS Negl Trop Dis. 2010; 4(1):e584.
5. Kheirandish F, Bandehpour M, Haghighi A, Mahboudi F, Mohebali M, Mosaffa N, et al. Molecular cloning and expression of Iranian Leishmania major pteridine reductase 1. Iranian J Parasitol. 2008; 3(2):1-9.
6. Decuypere S, Vanaerschot M, Brunker K, Imamura H, Müller S, Geary TG. Molecular Mechanisms of Drug Resistance in Natural Leishmania Populations. PLoS Negl Trop Dis. 2012; 6(e):1514.
7. Kothari H, Kumar P, Sundar S, Singh N. Possibility of membrane modification as a mechanism of antimony resistance in Leishmania donovani. Parasitol Int. 2007; 56(1):77.
8. Sundar S, More DK, Singh MK, Singh VP, Sharma S, Makharia A, et al. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis. 2000; 31(4):1104-7.
9. Hadighi R, Mohebali M, Boucher P, Hajjaran H, Khamesipour A, Ouellette M. Unrespo-nsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites. PLoS Med. 2006; 3(5):e162.
10. Jeddi F, Piarroux R, Mary C. Antimony Resistance in Leishmania, Focusing on Experimental Research. J Trop Med. 2011; 2011
11. Gourbal B, Sonuc N, Bhattacharjee H, Legare D, Sundar S, Ouellette M, et al. Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin. J Biol Chem. 2004; 279(30):31010-7.
12. Marquis N, Gourbal B, Rosen BP, Mukhopadhyay R, Ouellette M. Modulation in aquaglyceroporin AQP1 gene transcript levels in drugresistant Leishmania. Mol Microbiol. 2005; 57(6):1690-9.
13. Denton H, Mc GREGOR JC, Coombs GH. Reduction of anti-leishmanial pentavalent antimonial drugs by a parasite-specific thiol-dependent reductase, TDR1. Biochem J. 2004; 381(Pt 2):405.
14. Zhou Y, Messier N, Ouellette M, Rosen BP, Mukhopadhyay R. Leishmania major LmACR2 is a pentavalent antimony reductase that confers sensitivity to the drug pentostam. J Biol Chem. 2004; 279(36):37445-51.
15. Hansen C, Hansen EW, Hansen HR, Gammelgaard B, Stürup S. Reduction of Sb (V) in a human macrophage cell line measured by HPLC-ICP-MS. Biol Trace Elem Res. 2011; 144(1):234-43.
16. Rusnak F, Mertz P. Calcineurin: form and function. Phycol Res. 2000; 80(4):1483-521.
17. Hata R, Masumura M, Akatsu H, Li F, Fujita H, Nagai Y, et al. Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray. Biochem Biophys Res Commun. 2001; 284(2):310-6.
18. Guimond C, Trudel N, Brochu C, Marquis N, El Fadili A, Peytavi R, et al. Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays. Nucleic Acids Res. 2003; 31(20):5886-96.
19. t'Kindt R, Scheltema RA, Jankevics A, Brunker K, Rijal S, Dujardin JC, et al. Metabolomics to unveil and understand phenotypic diversity between pathogen populations. PLoS Negl Trop Dis. 2010; 4(11):e904.
20. Decorosi F, Viti C, Mengoni A, Bazzicalupo M, Giovannetti L. Improvement of the cDNA-AFLP method using fluorescent primers for transcription analysis in bacteria. J Microbiol Meth. 2005; 63(2):211-5.
21. Farahyar S, Zaini F, Kordbacheh P, Rezaie S, Safara M, Raoofian R, et al. Overexpression of aldo-keto-reductase in azole-resistant clinical isolates of Candida glabrata determined by cDNA-AFLP. DARU. 2013; 21(1).
22. Kazemi-Rad E, Mohebali M, Hajjaran H, Rezaei S, Mamishi S. Diagnosis and characterization of Leishmania species in Giemsa-stained slides by PCR-RFLP. Iran J Public Health. 2008; 37(1):
23. Saffari M, Dinehkabodi OS, Ghaffari SH, Modarressi MH, Mansouri F, Heidari M. Identification of novel p53 target genes by cDNA AFLP in glioblastoma cells. Cancer Lett. 2009; 273(2):316-22.
24. Klee CB, Ren H, Wang X. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem. 1998; 273(22):13367-70.
25. Odom A, Muir S, Lim E, Toffaletti DL, Perfect J, Heitman J. Calcineurin is required for virulence of Cryptococcus neoformans. The EMBO Journal. 1997; 16(10):2576-89.
26. Blankenship JR, Wormley FL, Boyce MK, Schell WA, Filler SG, Perfect JR, et al. Calcineurin is essential for Candida albicans survival in serum and virulence. Eukaryot Cell. 2003; 2(3):422-30.
27. Kudla J, Xu Q, Harter K, Gruissem W, Luan S. Genes for calcineurin B-like proteins in Arabidopsis are differentially regulated by stress signals. Proc Natl Acad Sci U S A. 1999; 96(8):4718-23.
28. Yoshida T, Toda T, Yanagida M. A calcineurin-like gene ppb1+ in fission yeast: mutant defects in cytokinesis, cell polarity, mating and spindle pole body positioning. J Cell Sci. 1994; 107(7):1725-35.
29. Naderer T, Dandash O, McConville MJ. Calcineurin is required for Leishmania major stress response pathways and for virulence in the mammalian host. Mol Microbiol. 2011; 80(2):471-80.
30. Aramburu J, Heitman J, Crabtree GR. Calcineurin: a central controller of signalling in eukaryotes. EMBO reports. 2004; 5(4):343.
31. Dhein J, Walczak H, Bäumler C, Debatin KM, Krammer PH. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature. 1995; 373(6513):438-41.
32. Bishopric NH, Andreka P, Slepak T, Webster KA. Molecular mechanisms of apoptosis in the cardiac myocyte. Curr Opin Pharmacol. 2001; 1(2):141-50.
33. Shaha C. Apoptosis in Leishmania species & its relevance to disease pathogenesis. Indian J Med Res. 2006; 123(233-44).
34. Lindoso JAL, Cotrim PC, Goto H. Apoptosis of Leishmania (Leishmania) chagasi amastigotes in hamsters infected with visceral leishmaniasis. Int J Parasitol 2004; 34(1):1-4.
35. Sudhandiran G, Shaha C. Antimonial-induced increase in intracellular Ca2+ through non-selective cation channels in the host and the parasite is responsible for apoptosis of intracellular Leishmania donovani amastigotes. J Biol Chem. 2003; 278(27):25120-32.
36. Sereno D, Holzmuller P, Mangot I, Cuny G, Ouaissi A, Lemesre JL. Antimonial-Mediated DNA Fragmentation in Leishmania infantum Amastigotes. Antimicrob Agents Chemother. 2001; 45(7):2064-9.